MedPath

Validating the Safety and Effectiveness of ENDOANGEL Lower Gastrointestinal Endoscope Image Auxiliary Diagnostic Software

Not Applicable
Completed
Conditions
Intestinal Polyps
Interventions
Other: Endoangel assisted the process of colonoscopy
Other: Colonoscopy was performed without endoangel assistance
Registration Number
NCT05481632
Lead Sponsor
Ruijin Hospital
Brief Summary

To evaluate the safety and effectiveness of ENDOANGEL Lower Gastrointestinal Endoscope Image Auxiliary Diagnostic Software developed and manufactured by Wuhan ENDOANGEL Medical Technology Co., Ltd.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1360
Inclusion Criteria
  • 18 years old ≤ age ≤ 75 years old, male or female;
  • Subjects with colonoscopy diagnosis and screening needs;
  • Sign the Written Informed Consent Form;
  • With full capacity for civil conduct.
Exclusion Criteria
  • History of acute myocardial infarction (within 6 months), severe heart, liver, and renal insufficiency or mental disease;
  • Patients who are taking aspirin, warfarin, and other anticoagulants;
  • Patients with inflammatory bowel disease, or polyposis syndromes, or confirmed or highly suspected colon cancer;
  • History of colorectal surgery;
  • Patients with familial adenomatous polyposis;
  • Pregnant women (if the subject is a woman of reproductive age and cannot confirm whether she is pregnant, a pregnancy test is required);
  • Patients who are participating in clinical trials of other drugs or medical devices;
  • Patients who are not eligible to participate in this clinical trial in the opinion of the investigator.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physician AI-assisted diagnosis groupEndoangel assisted the process of colonoscopy-
Physician Independent Diagnostic GroupColonoscopy was performed without endoangel assistance-
Primary Outcome Measures
NameTimeMethod
sensitivity of polyps identification3 months

The numerator is the number of true positives and the denominator is the total number of true positives and false negatives.

specificity of polyps identification3 months

The numerator is the number of true negatives and the denominator is the total number of true negatives and false positives.

Secondary Outcome Measures
NameTimeMethod
Polyp detection rate3 months

The numerator is subjects with polyps detected and the denominator is all subjects.

Trial Locations

Locations (1)

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath